Full Text (PDF)
Review Article

Current Guidelines for Vascular Anomalies Management

Ravi Kumar Chittoria, Amrutha J.S.

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator


Journal of Cardiovascular Medicine and Surgery 9(3-4):p 55-64, July-December 2023. | DOI: http://dx.doi.org/10.21088/jcms.2454.7123.9323.3

How Cite This Article:

Amrutha JS, Chittoria RK. Current guidelines for vascular anomalies management. J Cardiovasc Med Surg. 2023;9(3-4):55–64.

Timeline

Received : September 20, 2023         Accepted : November 01, 2023          Published : December 30, 2023

Abstract

Vascular anomalies are a heterogeneous group of rare and complex disease that can occur anywhere in the human body. These anomalies pose a major challenge in diagnosis and treatment because of their multiple clinical presentations and anatomic variations. The treatment of vascular anomalies requires a multidisciplinary approach involving specialists from different medical fields such as radiology, interventional radiology, plastic surgery, vascular surgery, dermatology and hematology. The key to effective treatment lies in the accurate diagnosis and classification of these lesions, which can be achieved through a combination of clinical evaluation, imaging studies, and histopathologic analysis. Treatment modalities for vascular malformations include a wide range of options, including conservative observation, minimally invasive techniques, and surgical intervention. Noninvasive methods such as compression garments and sclerotherapy have been shown to be effective in vascular anomalies.


References

  • 1.   ISSVA Classification of Vascular Anomalies© 2014 International Society for the Study of Vascular Anomalies. http://www.issva.org/classification. Accessed Apr 2014.
  • 2.   Trop I, Dubois J, Guibaud L, Grignon A, Patriquin H, McCuaig C, Garel LA. Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US. Radiology. 1999 Sep;212(3):841-5.
  • 3.   Gold L, Nazarian LN, Johar AS, Rao VM. Characterization of maxillofacial soft tissue vascular anomalies by ultrasound and color Doppler imaging: an adjuvant to computed tomography and magnetic resonance imaging. J Oral Maxillofac Surg 2003;61 (1) 19-31.
  • 4.   Yoshida H, Yusa H, Ueno E. Use of Doppler color flow imaging for differential diagnosis of vascular malformations: a preliminary report. J Oral Maxillofac Surg 1995;53 (4) 369-374
  • 5.   Konez O, Hopkins KL, Burrows PE. Pediatric techniques and vascular anomalies. In CT and MR Angiography. Rubin GD, Rofosky NM. 1118-1187. Lippincott, 2009.
  • 6.   Legiehn GM, Heran MK. Classification, diagnosis, and interventional radiologic management of vascular malformations. Orthop Clin North Am. 2006;37(3):435-74
  • 7.   Dubois J, Patriquin HB, Garel L, Powell J, Filiatrault D, David M, Grignon A. Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography. AJR Am J Roentgenol. 1998 Jul; 171(1):247-52
  • 8.   Dentici R, Mattasi R, Vaghi M. La diagnostica per immagini in medicina nucleare. Capitolo 19. In: Mattassi, Belov S, Loose DA, Vaghi M (eds). pp 32- 39. Malformaziono vascolari ed emangiomi. Testoatlantie di diagnostica e terapia, Springer-Verlag, Milano, Italy
  • 9.   Lee BB, Kim BT, Choi JY, Cazaubon M: Prise en charge des malformations vasculaires congénitales (MVC) en 2003: rôle de la scintigraphy corps entier dans las surveillance évolutive. Angeiologie 55(3): 17-26, 2003.
  • 10.   Hollerman JJ, Bernstein MA, Froelich JW, Schkudor G. Detection of hemangiomas using whole-body imaging with technetium-99m labeled RBCs, Clin Nucl Med. 1986 Oct;11(10):716-7
  • 11.   Lee BB, Baumgartner I, Berlien HP, Bianchini G, Burrows P, Do YS, Ivancev K, Kool LS, Laredo J, Loose DA, Lopez-Gutierrez JC, Mattassi R, Parsi K, Rimon U, Rosenblatt M, Shortell C, Simkin R, Stillo F, Villavicencio L, Yakes W. Consensus Document of the International Union of Angiology (IUA)-2013. Current concept on the management of arteriovenous malformation. Int Angiol. 2013 Feb;32(1):9- 36
  • 12.   Lee B, Andrade M, Bergan J, Boccardo F, Campisi C, Damstra R, Flour M, Gloviczki P, Laredo J, Piller N, Michelini S, Mortimer P, Villavicencio JL; International Union of Phlebology. Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2009
  • 13.   Lee BB, Andrade M, Antignani PL, Boccardo F, Bunke N, Campisi C, Damstra R, Flour M, FornerCordero J, Gloviczki P, Laredo J, Partsch H, Piller N, Michelini S, Mortimer P, Rabe E, Rockson S, Scuderi A, Szolnoky G, Villavicencio JL. Diagnosis and Treatment of Primary Lymphedema. Consensus Document of the International Union of Phlebology (IUP)-2013. Int Angiol 2013;32(6):541-74
  • 14.   Lee BB, Bergan J. Gloviczki P, Laredo J, Loose DA, Mattassi R, Parsi K, Villavicencio JL, Zamboni P: Diagnosis and treatment of venous malformations - Consensus Document of the International Union of Phlebology (IUP)-2009. International Angiology 2009 December;28(6):434-51
  • 15.   Apak H, Celkan T, Ozkan A. et al. Blue rubber bleb coagulopathy: treatment with interferon. Dermatology 2004;208 (4) 345-348
  • 16.   Sapp JC, Turner JT, van de Kamp JM, van Dijk FS, Lowry RB, Biesecker LG. Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients. American journal of medical genetics Part A. 2007;143A(24): 2944-58
  • 17.   Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008 Jun 12. 358 (24):2649-51. [QxMD MEDLINE Link].
  • 18.   Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013 Jan. 131 (1):128-40. [QxMD MEDLINE Link]. [Full Text].
  • 19.   Antaya RJ. Infantile hemangioma. Medscape Drugs & Diseases. Available at https://emedicine. medscape.com/article/1083849-overview. November 9, 2020; Accessed: October 4, 2021.
  • 20.   Wang Y, Zhu F, Ning JL, Li XJ, Liu Y. [Application of 1% lauromacrogol in the treatment of facial refractory hemangioma and vascular malformations]. Zhonghua Zheng Xing Wai Ke Za Zhi. 2012 Nov. 28 (6):428-31. [QxMD MEDLINE Link]. [Full Text].
  • 21.   Steiner F, FitzJohn T, Tan ST. Ethanol sclerotherapy for venous malformation. ANZ J Surg. 2016 Oct. 86 (10):790-795. [QxMD MEDLINE Link].
  • 22.   Veräjänkorva E, Rautio R, Giordano S, Koskivuo I, Savolainen O. The Efficiency of Sclerotherapy in the Treatment of Vascular Malformations: A Retrospective Study of 63 Patients. Plast Surg Int. 2016. 2016:2809152. [QxMD MEDLINE Link].
  • 23.   Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg. 2005 Jan. 32 (1):99- 116, ix. [QxMD MEDLINE Link].
  • 24.   Arneja JS, Gosain AK. Vascular malformations. Plast Reconstr Surg. 2008 Apr. 121 (4):195e-206e. [QxMD MEDLINE Link]
  • 25.   Okada A, Kubota A, Fukuzawa M, Imura K, Kamata S. Injection of bleomycin as a primary therapy of cystic lymphangioma. J Pediatr Surg. 1992 Apr. 27 (4):440-3. [QxMD MEDLINE Link].
  • 26.   Greinwald JH Jr, Burke DK, Sato Y, Poust RI, Kimura K, Bauman NM, et al. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg. 1999 Oct. 121 (4):381-7. [QxMD MEDLINE Link].
  • 27.   Burrows PE, Mitri RK, Alomari A, Padua HM, Lord DJ, Sylvia MB, et al. Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol. 2008. 6 (3-4):209-16. [QxMD MEDLINE Link]
  • 28.   Cronan J, Gill AE, Shah JH, Hawkins CM. The Role of Interventional Radiologists in the Treatment of Congenital Lymphatic Malformations. Semin Intervent Radiol. 2020 Aug. 37 (3):285-294. [QxMD MEDLINE Link]. [Full Text].
  • 29.   De Maria L, De Sanctis P, Balakrishnan K, Tollefson M, Brinjikji W. Sclerotherapy for lymphatic malformations of head and neck: Systematic review and meta-analysis. J Vasc Surg Venous Lymphat Disord. 2020 Jan. 8 (1):154-164. [Full Text]
  • 30.   Van Damme A, Seront E, Dekeuleneer V, Boon LM, Vikkula M. New and Emerging Targeted Therapies for Vascular Malformations. Am J Clin Dermatol. 2020 Oct. 21 (5):657-668. [QxMD MEDLINE Link].
  • 31.   Thirion S, Jamblin P, Demarche M, Boon L, Thiry A, Hoyoux C. [A new treatment for vascular anomalies: Six cases treated with rapamycin]. Arch Pediatr. 2017 Jul. 24 (7):600-606. [QxMD MEDLINE Link].
  • 32.   De Maria L, De Sanctis P, Balakrishnan K, Tollefson M, Brinjikji W. Sclerotherapy for lymphatic malformations of head and neck: Systematic review and meta-analysis. J Vasc Surg Venous Lymphat Disord. 2020 Jan. 8 (1):154-164. [Full Text].
  • 33.   Zide BM, Glat PM, Stile FL, Longaker MT. Vascular lip enlargement: Part I. Hemangiomas--tenets of therapy. Plast Reconstr Surg. 1997 Dec. 100 (7):1664- 73. [QxMD MEDLINE Link].
  • 34.   Lee BB, Do YS, Yakes W, Kim DI, Mattassi R, Hyon WS. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg. 2004 Mar. 39 (3):590-600. [QxMD MEDLINE Link].
  • 35.   Starke RM, Komotar RJ, Hwang BY, Fischer LE, Otten ML, Merkow MB, et al. A comprehensive review of radiosurgery for cerebral arteriovenous malformations: outcomes, predictive factors, and grading scales. Stereotact Funct Neurosurg. 2008. 86 (3):191-9. [QxMD MEDLINE Link]

Data Sharing Statement

There are no additional data available

Funding

This research received no funding

Author Contributions

All authors contributed significantly to the work and approve its publication

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval

Acknowledgements

Information Not Provided

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Amrutha JS, Chittoria RK. Current guidelines for vascular anomalies management. J Cardiovasc Med Surg. 2023;9(3-4):55–64.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator


Received Accepted Published
September 20, 2023 November 01, 2023 December 30, 2023

DOI: http://dx.doi.org/10.21088/jcms.2454.7123.9323.3

Keywords

GuidelinesVascular anomaliesManagement

Article Level Metrics

Last Updated

Monday 22 June 2026, 10:59:33 (IST)


681

Accesses

2
121
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received September 20, 2023
Accepted November 01, 2023
Published December 30, 2023

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator


Access this article



Share